Status:
WITHDRAWN
AntiCoagulation Tracking InterVention and Evaluation
Lead Sponsor:
University of California, San Francisco
Conditions:
Anticoagulation
Atrial Fibrillation
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Anticoagulants are a leading cause of acute injury from adverse drug events, leading to \~20,000 serious injuries reported to the Food and Drug Administration per year and more than 220,000 emergency ...
Eligibility Criteria
Inclusion
- Adults (age ≥18 years)
- those prescribed an anticoagulation medication at Zuckerberg San Francisco General Hospital or University of California, San Francisco Health
Exclusion
- Minors (age\<18)
- those not prescribed anticoagulation medication at ZSFG or UCSF Health
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04059965
Start Date
October 1 2022
End Date
September 30 2025
Last Update
August 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.